AAPCR is dedicated to advancing excellence in primary care research by fostering collaboration among healthcare professionals, researchers, and educators. We strive to promote innovative studies, share valuable knowledge, and support evidence-based practices that lead to better patient care, improved healthcare systems, and stronger community well-being.
Our vision is to be a trusted leader in primary care research worldwide, recognized for driving innovation, shaping healthcare policy, and empowering professionals with the resources they need to make a meaningful difference. We aim to create a future where primary care is guided by research-driven insights, ensuring healthier and more equitable communities for generations to come.
Family medicine
Godson Osuji and Remigius Okea are pioneering research scientists who have developed the largest known series of active biological molecules. These remarkable molecules, referred to as chimerenomic RNA, are unique macromolecular RNA that are produced independent of the genetic code. Each chimerenomic macromolecular RNA, also called NTinti, typically comprises 10.5 billion nucleotide bases (see references 1, 2, 3), and has a mass of approximately 3.57 x 10^12 Daltons, making it 1.7 times larger and longer than the human genome, which consists of 3.2 billion base pairs and weighs 2.04 x 10^12 Daltons. Indeed, chimerenomic macromolecular RNA is the largest active man-made molecule in the world.
These biologically active chimerenomic NTinti RNAs have proven invaluable across various fields, including biology, molecular chemistry, and medicine, leading to the emergence of new disciplines known as chimerenomic sciences. This innovative field is paving the way for the invention of breakthroughs because of the new understanding of previously inexplicable phenomena in science and medicine. Osuji and Okea have aptly dubbed these biologically active extra-large RNA molecules the "molecule of new life”
